Executive Director, Manufacturing

Secretome Therapeutics is a clinical-stage biotechnology company based in Plano, Texas, developing novel therapies derived from neonatal cardiac progenitor cells (nCPC). The Company's lead product candidate, STM-01, is a cellular therapy designed to modulate inflammatory and fibrotic pathways and support myocardial function in Duchenne Muscular Dystrophy (DMD) and Heart Failure with Preserved Ejection Fraction (HFpEF). Secretome is also advancing STM-21, a secretome-based therapeutic currently in preclinical development, and other novel nCPC-based products.

About the role

Serve as the Chief Technical Officer's operational deputy for Manufacturing and CMC execution, advancing Secretome's clinical and pipeline programs. This highly visible leadership role carries broad responsibility across GMP manufacturing, technology transfer, process scale-up, CDMO management, master cell banks, drug product, clinical supply, manufacturing readiness, and operational risk